Free Trial

Zentek Q2 2024 Earnings Report

Zentek logo
C$1.35 +0.04 (+3.05%)
As of 09:56 AM Eastern

Zentek EPS Results

Actual EPS
-C$0.03
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Zentek Revenue Results

Actual Revenue
$0.01 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Zentek Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Remove Ads

Zentek Earnings Headlines

Poverty is a choice
Wealth is a choice. So is poverty. I know because I’ve been both. I went from broke—driving a beat-up car and crashing on friends’ couches—to building wealth through sheer willpower. Then, I lost everything. I had to sell it all—cars, watches, real estate—until I was worth less than zero. In that moment, I had a choice: give up and surrender to the system or take control and rebuild. I chose the latter. Because once you rely on handouts, you may never break free. Welfare and bailouts aren’t a safety net—they’re handcuffs. So, I started over. And in doing so, I discovered a radically different way to build wealth—one that doesn’t depend on the stock market, the Fed, or the latest political circus. A contrarian strategy that helped me climb out of financial rock-bottom. Now, I’m sharing it with you. If you’re looking for a faster, safer, and more resilient way to secure your financial future—especially with a recession looming—this could be the key.
Want 6% Yield? The 3 TSX Stocks to Buy Today
See More Zentek Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Zentek? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zentek and other key companies, straight to your email.

About Zentek

Zentek (CVE:ZEN), together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

View Zentek Profile

More Earnings Resources from MarketBeat